Skip to main content
Premium Trial:

Request an Annual Quote

Sirius Genomics Teams with UK Genomics Group

NEW YORK (GenomeWeb News) — Sirius Genomics will collaborate with a UK research group focused on human disease gene studies to develop the company’s pharmacogenomic test for patient response to a drug treatment for infection and sepsis.
 
Sirius said today that the United Kingdom Critical Care Genomics Group will help develop its test for responsiveness to recombinant actived Protein C, which is marketed by Eli Lilly under the name Xigris.
 
"The UKCCG group is conducting a large genomic association study looking at severe life-threatening infections and sepsis,” Sirius Genomics CEO Brad Popovich said in a statement. He added that the collaboration will allow the company to “significantly advance the development of our diagnostic by accessing the comprehensive database that the UKCCG group has compiled.”
 
Financial terms of the agreement were not disclosed.

Filed under

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.